阿维菌素对畜禽体内外寄生虫驱治疗效的调查

阿维菌素是近十年来在甘肃省试点、示范和区域性推广应用的一种新型抗家畜体内外寄生虫的兽药,从1993年开始我省先后在兰州、张掖、武威、酒泉等7个地、州、市的22个县安排了80 000多只家畜体内外寄生虫的驱治试验、示范和推广工作,通过对家畜体内外寄生虫驱治试验疗效的观察,阿维菌素对羊的体内外寄生虫病和猪的体内外寄生虫病的驱治率分别达到95%～100%和94%～100%.驱治效果优于目前使用的其他抗寄生虫药物.     

Reduction of aflatoxin M1 in milk using hydrogen peroxide and hydrogen peroxide plus heat treatment.

Use of hydrogen peroxide (H2O2) under various conditions of temperature and time to inactivate aflatoxin M1 in artificially contaminated raw milk was examined. The degree of inactivation was measured by Enzym Linked Immunosorbent Assay (ELISA). It appeared that there is no change in the content of aflatoxin M1 in milk contained H2O2 and examined after 24 hours without heat treatment and in contaminated milk without add of H2O2 and heat treated treatment at (63 degrees C for 30 min, 75 degrees C for 15 sec) but slight inactivation (4.3%) was obtained in milk boiled for 5 min without H2O2. Maximum inactivation (27.8%, 28.8% and 45.1%) were obtained using 1% H2O2 followed by heat treatment at 36 degrees C for 30 min, 75 degrees C for 15 sec and boiling for 5 min respectively.     

2种消毒剂对猪舍自然菌的消毒效果

为了考察戊二醛苯扎溴铵溶液、复方戊二醛溶液2种消毒剂对猪舍自然菌的现场消毒效果,参考中华人民共和国农业部《兽用消毒剂技术规范》(1992年版),采用戊二醛苯扎溴铵溶液100倍稀释、复方戊二醛溶液150倍稀释,通过擦拭法进行消毒前后表面菌落计数,计算杀菌率,判定其现场消毒效果。结果显示:戊二醛苯扎溴铵溶液100倍稀释,复方戊二醛溶液150倍稀释时,与猪舍自然菌作用60 min,杀菌率达96.45%以上。结果表明:2种消毒剂对猪舍自然菌消毒效果相当,戊二醛苯扎溴铵溶液可以推广使用。     

南京地区观赏草的适应性和利用价值初步评价

对3科17属30种(27份从国外引进栽培的观赏草和3份南京本土引种的材料)观赏草外部性状、物候期、抗寒性、耐热性、抗病虫性和整株、花序、叶的观赏性进行跟踪观测,评价并分析其在南京地区的适应性和观赏价值,分成A-E 5个等级.A级:细茎针茅Nassella tenuissima、矮蒲苇Cortaderia selloana 'Pumila',具有很好的观赏性和南京地区适应能力,完全适合在南京地区推广;B级:紫田根Saccharum arundinaceum、柳枝稷Panicum virgatum 'Rehbraun'、发状苔草Carex albula、皱苞苔草C. chungii C.P.Wang、蓝灰石竹Dianthus gratianopolitanus 'Bath's pink'、甜茅S.ravennae、狼尾草Pennisetum、棕榈叶苔草C. muskingumensis、歌舞芒Miscanthus sinensis 'Cabaret'、芦竹Arundo donax、劲芒M. sinensis 'Strictus'、小盼草Chasmanthium latifolium,有较好观赏性和地区适应性,可以在南京地区推广;C级:宽叶苔草C.flacca、Sorghastrum nutans、金边苔草C. oshimenis 'Gold Strike'、巨针茅Stipa gigantea、斑叶苔草C.variegated、遍生芒M.sinensis 'Cosmopolitan'、花叶虉草Phalaris arundinacea 'Picta'、晨光芒M.sinensis 'Morning light'、拂子茅Calamagrostis overdam,具有一定的观赏价值,但个别指标评分低,应用时增加保护措施;D级:桔红苔草C.testacea、红叶白茅Imperata cylindrica 'Red Baron'、褐红苔草C.comans 'Bronze'、球茎燕麦Arrhenatherum elatius subsp.Bulbosum、花叶芦竹Arundo donax 'Variegata'、画眉草Eragrostis spectabilis,关于花序表现的几个指标评价均较低,影响总体评价,可以在南京地区推广但不适合观花,可以作为观叶植物;E级:金黄蒲苇Cortaderia selloana 'Aureolineata'各项指标评分都较低,不适合在南京地区推广.     

Clinical and in vitro efficacy of amoxicillin against bacteria associated with feline skin wounds and abscesses

A clinical trial involving 122 cats with infected skin wounds or abscesses presented to 10 veterinary clinics was conducted to evaluate the efficacy of 2 oral amoxicillin drug products (a paste and a suspension). A 2nd objective of the study was to identify bacteria involved in such infections and verify their in vitro sensitivity to amoxicillin. Samples of wound exudate were harvested at the time of presentation and submitted for aerobic and anaerobic culture. The sensitivity to amoxicillin of isolates thought to be infecting agents was tested, using a standard minimum inhibitory concentration method. Pasteuralla multocida and obligate anaerobes of the genera Prevotella, Fusobacterium, and Porphyromonas were the most frequently isolated pathogens. Overall, their in vitro susceptibility to amoxicillin was very good. Both drug products were clinically efficacious with a global success rate of 95.1% for cats administered oral amoxicillin at 11-22 mg/kg bodyweight (mean 13.8 mg/kg bodyweight) twice daily for 7 to 10 days.     

Effects of alkaline hydrogen peroxide treatment of wheat straw on site and extent of digestion in sheep

Two experiments (4 X 4 Latin squares) were conducted, using four multiple-cannulated wethers (mean body weight, 65 kg), to determine effects of treating wheat straw (WS) with alkaline solutions (pH 11.5) of hydrogen peroxide (AHP; .26 g hydrogen peroxide/g WS) on site and extent of nutrient digestion in sheep. Diets contained either 33 to 37% (low WS) or 70 to 72% (high WS) AHP-treated (T) or non-treated (C) WS. Treatment of WS with AHP resulted in increased acid detergent fiber and cellulose concentrations and decreased acid detergent lignin (ADL) concentrations compared with non-treated WS. In Exp. 1, intakes were held constant at approximately 1,044 g dry matter (DM)/d. When fed AHP-treated WS diets, wethers digested more (P less than .05) DM, neutral detergent fiber (NDF) and cellulose in the stomach (54.8, 47.4, 51.6 and 20.0%; 65.6, 68.8, 51.5 and 37.2%; 66.6, 74.2, 45.2 and 40.7% of intake, respectively, for low WS-T, high WS-T, low WS-C and high WS-C diets) and in the total tract (83.0, 74.8, 68.4 and 50.0%; 81.8, 81.0, 53.9 and 42.1%; 85.2, 86.9, 50.2 and 47.6%, respectively, for the low WS-T, high WS-T, low WS-C and high WS-C diets), and had lower (P less than .05) ruminal pH than when fed the non-treated WS diets. In Exp. 2, the same wethers were fed diets similar to those fed in Exp. 1, but at ad libitum intake. Wethers consumed less (P less than .05) feed when fed the high WS-C diet than when fed the other three diets (2,234, 2,526, 2,271 and 1,297 g/d for the low WS-T, high WS-T, low WS-C and high WS-C diets, respectively). Digestibilities of DM, NDF and cellulose were higher (P less than .05) when sheep were fed the treated WS diets than when fed the non-treated WS diets (82.7, 70.7, 68.4 and 58.0%; 78.6, 72.9, 49.4 and 51.6%; 78.0, 84.0, 53.8 and 37.5%, respectively, for the low WS-T, high WS-T, low WS-C and high WS-C diets). Fluid and particulate dilution rates in the rumen were higher (P less than .08) when wethers consumed AHP-treated WS diets compared with non-treated WS diets (8.21, 8.56, 6.96 and 6.81%/h; 6.06, 6.73, 4.05 and 3.15%/h, respectively, for the low WS-T, high WS-T, low WS-C and high WS-C diets). The AHP treatment was successful in overcoming the major barriers to microbial degradation of WS in the gastrointestinal tract of wethers.     

A non-lethal method for assessment of efficacy of antiparasitics against parasites in horses such as Anoplocephala perfoliata and Gasterophilus intestinalis

Sourcing of horses naturally infected with parasites such as Anoplocephala perfoliata and Gasterophilus intestinalis for antiparasitic efficacy slaughter studies is often difficult, expensive, and usually excessive numbers of animals must be slaughtered before significant data can be obtained. To overcome this problem a "Modified Critical Treatment Method" was developed. This method does not require the horses to be sacrificed, but relies on the collection and processing of all faecal material containing expelled parasites from test animals. Efficacy is assessed by comparing, in the same horses, the numbers of parasites expelled with the test compound with the total numbers removed with test and reference endectocides. This, for the most part, means that farms that were previously unavailable, e.g. studs, can now be used for the collection of efficacy data.     

In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients

OBJECTIVE: To evaluate the in vitro efficacy of polyhexamethylene biguanide (PHMB)-impregnated gauze dressing in limiting the growth of bacteria both within and underneath the dressing. STUDY DESIGN: In vitro study. METHODS: Squares of PHMB-impregnated and control gauze were placed on agar plates inoculated with 1 of 11 bacterial species, including 8 multi-resistant organisms. Growth under the gauze was assessed qualitatively after 24-hour incubation. Repeated use of sponges was used to evaluate residual inhibitory activity against Micrococcus lutea and Staphylococcus schleiferi ss. schleiferi. In a second procedure, PHMB-impregnated and control gauze squares were placed in sterile plastic wells and inoculated with 1 of 5 bacterial species, including Pseudomonas spp. and Klebsiella spp. Inhibition of bacterial growth within and underneath the dressing after 24-hour incubation was evaluated by quantifying the numbers of bacteria on the well floor and within each square. RESULTS: PHMB-impregnated gauze provided greater inhibition of growth of 4/4 Gram-positive species and 2/6 Gram-negative species on inoculated plates compared with control gauze. Residual inhibitory activity of PHMB-impregnated gauze was significantly greater against M. lutea on all days and against S. schleiferi ss. schleiferi on days 1 and 4 compared with control. No bacteria were recovered from inoculated PHMB-impregnated gauze squares placed in sterile wells or from the well floor underneath. More than 9 x 10(5) colony-forming units (CFU) were recovered from inoculated control samples placed in sterile wells and more than 8.4 x 10(4) CFU were recovered from control well floors. CONCLUSION: PHMB-impregnated gauze dressing, when placed on inoculated agar plates, reduces growth of underlying bacteria, particularly Gram-positive species. Wet-inoculated PHMB-impregnated dressing prevents growth of Gram-positive and Gram-negative bacteria both within and underneath the dressing. CLINICAL RELEVANCE: PHMB-impregnated dressings may be useful for reducing contamination of underlying wounds by bacterial pathogens.     

Efficacy of albendazole against nematode parasites isolated from a goat farm in Ethiopia: relationship between dose and efficacy in goats

A suspected case of albendazole resistance in a goat farm of Hawassa University was examined using faecal egg count reduction test (FECRT), controlled anthelmintic efficacy test and egg hatch assay (EHA) to verify the development of resistance and/or the need for higher doses of the drug in goats than in sheep. The experiment was conducted in 12 sheep (2 groups: treatment versus control) and 24 goats (4 groups: 3 treatments versus control, n = 6; per group) following artificial infection with infective larvae of Haemonchus contortus and Oesophagostomum columbianum. The first group of sheep and goats were treated orally with albendazole at the dose rate of 3.8 mg/kg body weight (i.e. manufacturer's recommended dose for sheep) while the second group of sheep and the fourth group of goats were left untreated. The second and the third group of goats were treated with albendazole at 5.7 and 7.6 mg/kg respectively. The FECRT showed an efficacy of albendazole in goats to be 65.5, 81.4 and 84.1% at the dose rate of 3.8, 5.7 and 7.6 mg/kg body weight respectively while in sheep it was 62% at the dose rate of 3.8 mg/kg. Increasing the dose to 1.5 the sheep recommended dose induced minor improvement of efficacy in goats; however the efficacy was almost the same at 1.5 and twice the dose recommended for sheep. Worm counts at day 15 post-treatment revealed that H. contortus has developed resistance to albendazole. EHA results also supported these findings. On the other hand, O. columbianum was 100% susceptible at all dose levels tested.     

生态王对雏鸡细菌性疾病防治效果及对体液免疫影响的初步研究

用健康鸡盲肠的厌氧培养物制成的微生态制剂生态王，用不同途径给刚出壳2日龄的雏鸡饲喂，再用致病性大肠杆菌及沙门氏杆菌给鸡攻毒。结果表明，试验鸡无论是口服还是饮水摄入生态王，都能明显提高对致病菌的抵抗力。雏鸡无论是从2日龄还是从7日龄开始用该制剂，都有明显效果，但日龄越小效果越明显。此外，微生态制剂对疫苗的免疫有显著的增强作用。     

Preliminary clinical pharmacological investigations of tylosin and tiamulin in chickens

Summary The minimal inhibitory concentrations (M1C) of tiamulin and tylosin for mycoplasma. Gram-positive, and Gram-negative micro-organisms isolated from chickens were determinated by the agar dilution method. Median M1C values for tiamulin against Mycoplasma gallisepticum (0.05 μg/ml) and Mycoplasma synoviae (0.10 μg/ml) were 2 to 4 times lower than the corresponding values for tylosin. Tiamulin was also slightly more effective in vitro in inhibiting Escherichia coli, Pasteurella multocida, and beta-haemolytic streptococci than was tylosin. Groups of chicken were offered tiamulin medicated drinking water at rates of 125 and 250 mg/litre for 48 hours. Average serum tiamulin concentrations were 0.38 and 0.78 μg/ml, respectively. When tylosin tartrate was added to the drinking water at 500 and 700 mg/litre, average serum drug levels were 0.12 and 0.17 μg/ml, respectively. Tiamulin was 45% bound in chicken serum, as against 30% serum protein binding or tylosin. Correlations were made between free (non protein bound) serum drug levels and the MIC values of the two drugs. Such comparisons suggest that when tiamulin is given in the drinking water at rates of 125 to 250 mg/litre, better antimycoplasmal activity is to be expected in vivo than by giving tylosin tartrate in the drinking water at 500 to 700 mg/litre. Based on these data, no clinical efficacy of these dose rates can be expected in flocks infected by gram-negative microorganisms such as E. coli or P. multocida. The tylosin tartrate rate of 500 to 700 mg/litre, may be clinical ineffective the treatment of Staphylococcus aureus infections.     

Preliminary clinical pharmacological investigations of tylosin and tiamulin in chickens

Summary

The minimal inhibitory concentrations (M1C) of tiamulin and tylosin for mycoplasma. Gram‐positive, and Gram‐negative micro‐organisms isolated from chickens were determinated by the agar dilution method. Median M1C values for tiamulin against Mycoplasma gallisepticum (0.05 μg/ml) and Mycoplasma synoviae (0.10 μg/ml) were 2 to 4 times lower than the corresponding values for tylosin. Tiamulin was also slightly more effective in vitro in inhibiting Escherichia coli, Pasteurella multocida, and beta‐haemolytic streptococci than was tylosin. Groups of chicken were offered tiamulin medicated drinking water at rates of 125 and 250 mg/litre for 48 hours. Average serum tiamulin concentrations were 0.38 and 0.78 μg/ml, respectively. When tylosin tartrate was added to the drinking water at 500 and 700 mg/litre, average serum drug levels were 0.12 and 0.17 μg/ml, respectively.

Tiamulin was 45% bound in chicken serum, as against 30% serum protein binding or tylosin. Correlations were made between free (non protein bound) serum drug levels and the MIC values of the two drugs. Such comparisons suggest that when tiamulin is given in the drinking water at rates of 125 to 250 mg/litre, better antimycoplasmal activity is to be expected in vivo than by giving tylosin tartrate in the drinking water at 500 to 700 mg/litre. Based on these data, no clinical efficacy of these dose rates can be expected in flocks infected by gram‐negative microorganisms such as E. coli or P. multocida. The tylosin tartrate rate of 500 to 700 mg/litre, may be clinical ineffective the treatment of Staphylococcus aureus infections.     

Therapeutic efficacy of eprinomectin extended-release injection against induced infections of developing (fourth-stage larvae) and adult nematode parasites of cattle

The therapeutic efficacy of eprinomectin in an extended-release injection (ERI) formulation was evaluated against induced infections of developing fourth-stage larval or adult gastrointestinal and pulmonary nematodes of cattle in a series of six studies under two identical protocols (three each for developing fourth-stage larvae or adults) conducted in the USA, Germany or the UK (two studies at each location, one per stage).     

Anthelmintic resistance on goat farms in Georgia: efficacy of anthelmintics against gastrointestinal nematodes in two selected goat herds

Gastrointestinal nematode (GIN) parasitism is a major constraint to production of goats in the southeastern United States. The conventional method of control used by producers in this region is frequent use of anthelmintics during the warm season. Overuse of anthelmintics has led to an increase in the incidence of anthelmintic resistance in many parts of the world, but data on prevalence of anthelmintic resistance in GIN of goats in the southeastern United States are very limited. To address this issue, anthelmintic efficacy was determined in goat herds at the Fort Valley State University, Agricultural Research Station (FVSU-ARS) and the University of Georgia, College of Veterinary Medicine (UGA-CVM) using fecal egg count reduction (FECR) tests and DrenchRite((R)) larval development assays (LDA). At FVSU-ARS, 2-year-old Spanish goat does were randomly allocated to one of nine different treatment groups (n = 10): albendazole (ABZ; 20mg/kg body weight (BW)), fenbendazole (FBZ; 20mg/kg BW), ivermectin (IVM; 0.4 mg/kg BW), doramectin (DRM; 0.4 mg/kg BW), moxidectin (MOX; 0.4 mg/kg BW), levamisole (LEV; 12 mg/kg BW), morantel tartrate (MOR; 10mg/kg BW), a combination of IVM (0.4 mg/kg BW) and ABZ (20 mg/kg BW), and untreated controls. At UGA-CVM, goats were randomly allocated to one of five different treatment groups (n = 8): ABZ (20 mg/kg BW), IVM (0.4 mg/kg BW), MOX (0.4 mg/kg BW), LEV (12 mg/kg BW), and untreated controls. All drugs in both experiments were administered orally. Anthelmintic efficacy was calculated by comparing 14-day post-treatment FEC of treated and control animals, and percent reductions were interpreted using the World Association for the Advancement of Veterinary Parasitology guidelines for resistance. For the LDA, nematode eggs were isolated from pooled fecal samples of untreated control goats in each herd and used to perform DrenchRite((R)) assays. In the FVSU-ARS herd, MOX, LEV, the combination of IVM and ABZ, IVM, DRM, ABZ, MOR, and FBZ reduced FEC by 100, 91, 88, 78, 76, 62, 48, and 10%, respectively. In the UGA-CVM herd, MOX, LEV, ABZ and IVM, reduced FEC by 100, 94, 87, and 0%, respectively. In both herds moxidectin was the only drug tested that was fully effective. Results of the LDA were in agreement with results of the FECR tests for both herds. These data demonstrate the presence of GINs resistant to all three major anthelmintic classes in both goat herds.     

Confirmation of the efficacy of a combination tablet of spinosad and milbemycin oxime against naturally acquired infections of canine intestinal nematode parasites

Four separate controlled and blinded studies were conducted to confirm the dose of spinosad and milbemycin oxime (MO) administered orally in combination to dogs for the treatment and control of naturally acquired infections of adult whipworm (Trichuris vulpis), hookworm (Ancylostoma caninum) and ascarids (Toxocara canis, Toxascaris leonina). Dogs were allocated randomly based on pre-treatment quantitative nematode egg counts of each species of interest to one of two treatment groups of 10 or 11 animals each. In each study, spinosad and MO in combination, was given orally to dogs using the lower half (30-45 mg/kg spinosad; 0.5-0.75 mg/kg MO) of the US commercial dose band (30-60 mg/kg spinosad; 0.5-1.0mg/kg MO) of each active ingredient on Day 0 using a tablet formulation. A corresponding vehicle control group was treated similarly in each individual study. Dogs were necropsied post-treatment on Day 7/8. All nematodes in the intestinal tract collected at necropsy were identified and counted by species and stage. The spinosad and MO combination group demonstrated significantly different adult intestinal nematode efficacy in each individual study as compared to the vehicle control group. Efficacy values for whipworm, hookworm, T. canis and T. leonina were 100%, 99.8%, 100%, 93.3%, respectively. Minor non-serious adverse events were observed in a small number of control and treated dogs that were attributed primarily to the natural nematode infections. In summary, flavored spinosad and MO combination tablets administered orally to dogs were both safe and highly efficacious delivering >93% up to 100% adult intestinal nematode control in naturally infected dogs.